Copyright
©The Author(s) 2016.
World J Hepatol. May 28, 2016; 8(15): 649-658
Published online May 28, 2016. doi: 10.4254/wjh.v8.i15.649
Published online May 28, 2016. doi: 10.4254/wjh.v8.i15.649
Table 1 Model inputs and 2013 estimates
| Historical | Year | 2013 (Est.) | |
| HCV infected cases | 427890 (132720-829480) | 2013 | 428260 |
| AntiHCV prevalence | 1.0% (0.3%-2.0%) | 1.0% | |
| Total viremic cases | 342310 (106170-663580) | 2013 | 342310 |
| Viremic prevalence | 0.8% (0.3%-1.6%) | 0.8% | |
| Viremic rate | 80.0% | 80.0% | |
| HCV diagnosed (viremic) | 112270 | 2010 | 117250 |
| Viremic diagnosis rate | 32.8% | 34.2% | |
| Annual newly diagnosed | 4920 | 2010 | 4920 |
| New infections | 1950 | ||
| New infection rate (per 100K) | 4.7 | ||
| Treated | |||
| Number treated | 650 | ||
| Annual treatment rate | 0.2% | ||
| Risk factors | |||
| Number of active IDU with HCV | 31950 | ||
| Percent active IDU | 9.3% | ||
| Previous blood transfusion | 48420 | ||
| Percent previous blood transfusion | 14.1% |
- Citation: Ridruejo E, Bessone F, Daruich JR, Estes C, Gadano AC, Razavi H, Villamil FG, Silva MO. Hepatitis C virus infection in Argentina: Burden of chronic disease. World J Hepatol 2016; 8(15): 649-658
- URL: https://www.wjgnet.com/1948-5182/full/v8/i15/649.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i15.649